Endomyocardial biopsy--technical aspects experience and current status. An Indian perspective.
Our study ellucidates the utility of endomyocardial biopsy (EMB) in various cardiac-muscle disorders seen in a tropical country like India. The procedure has been successfully performed in 501 patients (572 procedures) at our centre from April 1985 to December 1992. This included 60 infants and children. The indications were dilated cardiomyopathy (DCM) in 214, non-specific aortoarteritis in 91, rheumatic heart disease in 75, restrictive cardiomyopathy in 45, constrictive pericarditis in 14 and miscellaneous in 62 patients. There was no mortality, however, one patient developed cardiac tamponade and another sustained ventricular tachycardia requiring cardioversion. There was transient atrial fibrillation in six patients and all these had acute rheumatic heart disease. Transient complete heart block occurred in six patients with underlying left-bundle branch-block. Histological examination of EMB revealed myocarditis in 34/214 (15.4%) patients in DCM group and helped in following up these cases on immunosuppressive treatment. In the presence of restrictive haemodynamics it could identify amyloidosis in four patients. It was also helpful in differentiating between endomyocardial fibrosis and chronic constrictive pericarditis. In patients with non-specific aorto-arteritis significant histological changes of inflammatory myocarditis were observed in patients especially in congestive heart failure. Furthermore, it was helpful in identifying the nature of cardiac tumour in one patient. Its utility has also been evaluated in disorders, including rheumatic heart disease, peripartum cardiomyopathy and systemic disorders like systemic lupus erythematosis. Even in the absence of cardiac-transplant programmes at national level we have found EMB to be a useful investigation in a tropical country like India.
Talwar
K K
KK
All Indian Institute of Medical Sciences, New Delhi.
Varma
S
S
Chopra
P
P
Wasir
H S
HS
D000293:Adolescent; D000328:Adult; D001025:Aortitis / Q000473:pathology; D001707:Biopsy, Needle / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D009202:Cardiomyopathies / Q000139:chemically induced / Q000473:pathology*; D002311:Cardiomyopathy, Dilated / Q000473:pathology; D002313:Cardiomyopathy, Restrictive / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D004317:Doxorubicin / Q000009:adverse effects; D004719:Endomyocardial Fibrosis / Q000473:pathology; D005260:Female; D016027:Heart Transplantation / Q000473:pathology; D006801:Humans; D007194:India; D007223:Infant; D008297:Male; D013677:Medical Laboratory Science; D008875:Middle Aged; D009205:Myocarditis / Q000473:pathology; D009206:Myocardium / Q000473:pathology*; D009210:Myofibrils / Q000473:pathology; D011446:Prospective Studies
D004317:Doxorubicin